XML 43 R27.htm IDEA: XBRL DOCUMENT
v3.20.4

Quarterly Financial Information (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Financial Information (Unaudited) | Quarterly Financial Information (Unaudited) The following tables represent our quarterly financial results (in thousands, except per share data):
| 2020 Calendar Quarter |  |
| First |  | Second 2 |  | Third |  | Fourth |  | Annual
Revenue | $ | 165,105 |  |  | $ | 165,169 |  |  | $ | 180,123 |  |  | $ | 176,783 |  |  | $ | 687,180 |
Income from operations | 4,365 |  |  | 12,906 |  |  | 37,356 |  |  | 25,876 |  |  | 80,503 |
Net income | 2,987 |  |  | 81,001 |  |  | 25,424 |  |  | 12,908 |  |  | 122,320 |
Net income attributable to ApolloMed | 4,052 |  |  | 7,044 |  |  | 16,713 |  |  | 10,057 |  |  | 37,866 |
Earnings per share - basic attributable to common stock 1 | $ | 0.11 |  |  | $ | 0.20 |  |  | $ | 0.46 |  |  | $ | 0.27 |  |  | $ | 1.04 |
Earnings per share - diluted attributable to common stock 1 | $ | 0.11 |  |  | $ | 0.19 |  |  | $ | 0.45 |  |  | $ | 0.26 |  |  | $ | 1.01 |
1 Quarterly earnings per share impacts may not add to full-year earnings per share impacts due to the difference in weighted-average common shares for the quarters versus the weighted-average common shares for the year. 2 Includes a pre-tax gain of $99.6 million related to sale of UCI (Note 6).
| 2019 Calendar Quarter |  |
| First |  | Second |  | Third |  | Fourth |  | Annual
Revenue | $ | 95,757 |  |  | $ | 130,050 |  |  | $ | 156,060 |  |  | $ | 178,751 |  |  | $ | 560,618 |
(Loss) income from operations | (3,307) |  |  | 14,728 |  |  | 10,066 |  |  | 10,933 |  |  | 32,420 |
Net (loss) income | (2,450) |  |  | 10,664 |  |  | 10,739 |  |  | (1,280) |  |  | 17,673 |
Net income attributable to ApolloMed | 140 |  |  | 3,545 |  |  | 3,704 |  |  | 6,727 |  |  | 14,116 |
Earnings per share - basic attributable to common stock 1 | $ | 0.00 |  |  | $ | 0.10 |  |  | $ | 0.11 |  |  | $ | 0.19 |  |  | $ | 0.41 |
Earnings per share - diluted attributable to common stock 1 | $ | 0.00 |  |  | $ | 0.09 |  |  | $ | 0.10 |  |  | $ | 0.18 |  |  | $ | 0.39 |
1 Quarterly earnings per share calculations may not add to full-year earnings per share calculations due to the difference in weighted-average common shares for the quarters versus the weighted-average common shares for the year.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration